WT1: Wilms’ Tumor gene by Jennifer Mackey. Wilms’ Tumor o NEPHROBLASTOMA in children o Discovered by Max Wilms in 1899 o WT1 is a tumor suppressor o 10-15%

Slides:



Advertisements
Similar presentations
Early Embryonic Development Maternal effect gene products set the stage by controlling the expression of the first embryonic genes. 1. Transcription factors.
Advertisements

Cancer: a genetic disease of inherited and somatic mutations n Gene mutations and/or genetic instability are involved in many cancers. n Viruses and environmental.
Elizabeth M. Whitley, DVM, PhD, Dipl. ACVP 1 Isabel Hurtado Rodriguez, DVM, MS, Dipl. ACVIM 2 Amelia S. Munsterman, DVM, MS, Dipl. ACVS 2 1 Department.
Gene regulation in cancer 11/14/07. Overview The hallmark of cancer is uncontrolled cell proliferation. Oncogenes code for proteins that help to regulate.
What is Li-Fraumeni syndrome?
TSC2 and Tuberous Sclerosis Complex Disease Laura Koontz Biology 169.
E2A and acute lymphoblastic leukemias (ALL). A closer look at the E2A gene... Other names: TCF3, ITF1, and Factors E12/E47 Located on chromosome 19 Encodes.
ZAFIA ANKLESARIA Role of BMPR1A in Juvenile Polyposis Syndrome Biology 169.
Wilms’ Tumor Nephroblastoma Affects 1:10,000 children ~8% of all pediatric Malignancies 80% of these tumors can be successfully treated.
P53 The Master Guardian. R point Cell cycle control involves several checkpoints and checkpoint (molecular breaking) mechanisms.
Theories of cancer genesis
Von Hippel-Lindau Syndrome (VHL) Presented by Kelley Montoya March 20, 2003.
P73 Shatil Amin March 27 th Content I.Structure and Function II.Regulation III.Is it involved in human cancers?
P53 gene mutations in human tumors Greenblatt et al. (1995) Cancer Res. 54: %
 MicroRNAs (miRNAs) are a class of small RNA molecules, about ~21 nucleotide (nt) long.  MicroRNA are small non coding RNAs (ncRNAs) that regulate.
BRCA1 The First Breast Cancer Gene Presentation By Liz Mosley.
BRCA Genes Dallas Henson.
Proteins, Mutations and Genetic Disorders. What you should know One gene, many proteins as a result of RNA splicing and post translational modification.
Tumor Supressor Gene Non-functional TSG Mutations increasing risk of cancer “Loss of function” mutation Proto-oncogene Oncogene (Hyperactive or unregulated.
I. Role of Gene Expression  Gene expression is the activation (“turning on”) of a gene ◦ Separation of fingers and toes Genome: complete genetic material.
Cancer --an Overview  Cell Division  Hormones and Cancer  Malignant Transformation  Angiogenesis and Metastasis  Growth.
Group Number: 2 Britney Porter, Sandra Nguyen, Eduardo Vargas and Samender Singh Randhawa.
The Effect of BRCA1 on the Progesterone Receptor.
WT1 and Wilms Tumor Joshua Chen. Homozygous mutant mice are embryonic lethal and fail to develop kidneys and gonads, with additional defects in the heart,
Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene The journal of Clinical Investigation 112: (2003) Lien Hsu.
BRCA1: Tumor Suppression and Breast Cancer A breast cancer cell dividing.
P53 Missense Mutation Cancer. Outline Disease related to p53 Role and regulation pathway Structure of p53 Missense mutation and consequences Experiment’s.
Problem 1 James is the only person in his kindred affected by DMD. He has one unaffected brother, Joe. DNA analysis show that James has a deletion in the.
Eukaryotic Genomes 15 November, 2002 Text Chapter 19.
Genetics of Cancer Lecture 34.
1 Tumors of Urinary Tract. 2 Urinary Tract Neoplasm KidneyRenal Cell Carcinoma [ adult], Transitional cell carcinoma [ adult], Wilms Tumor [children]
Mutational analysis of 35 bladder cancer cell lines using RNA-seq.
ROLE OF GENE EXPRESSION:  Activation of a gene that results in a protein  Cells DO NOT need to produce proteins for every code. GENOME:  Complete genetic.
Cancer Detection and Diagnosis Early Cancer May Not Have Any symptoms Pap Test Mammograms Blood tests Prostate-specific antigen (PSA) Carcinoembryonic.
Javad Jamshidi Fasa University of Medical Sciences, December 2015 Cancer Genetics Session 4 Medical Genetics.
Eukaryotic Genomes 11 November, 2005 Text Chapter 19.
WT1 and Wilms’ Tumor Sarah DeHart. DNA-binding transcription factor Protein carries 4 C-terminal zinc fingers 36 different isoforms based on splicing.
Types of Genes Associated with Cancer
TSC1/Hamartin and Facial Angiofibromas Biology 169 Ann Hau.
Malignant Renal tumors DR.Gehan Mohamed. Malignant renal tumors - It may be: - primary tumors : i.e arise from kidney tissue itself - Secondary tumors:
Lucas Thornblade, MD Resident Physician Department of Surgery University of Washington.
Tumor-suppressor genes Tumor-suppressor genes, function like brakes, keep cell numbers down, either by inhibiting progress through.
EUKARYOTIC CELL SIGNALING VII Abnormal Signaling in Cancer Signaling to p53 Dr. Ke Shuai Office: 9-240M Factor Tel: X69168
Orkhon Tsogtbaatar, ID: April 18, 2012
Wilms tumor suppressor, Wt1, is a transcriptional activator of the erythropoietin gene by Christof Dame, Karin M. Kirschner, Katharina V. Bartz, Thomas.
Page 1 Wilms tumor 1 —by Creative BioMart. Page 2 Official Full Name Wilms tumor 1 Background Wilm’s Tumor (WT), a sporadic and familial childhood kidney.
Wilms tumor 1 —by Creative BioMart.
GENETIC BASIS OF CANCER
VHL & von Hippel-Lindau syndrome
WT1 – A Complex Life By: Chen Zhu.
The Genetic Basis of Cancer
Cancer.
Cancer Metabolism: A New Treatment Approach
What makes a mutant?.
Tuberous Sclerosis TSC2/ Tuberin Alison Chappell.
von Hippel-Lindau Disease
Concept 18.5: Cancer results from genetic changes that affect cell cycle control The gene regulation systems that go wrong during cancer are the very same.
Genetics of Cancer.
The promise of cancer genetics
Notch1 and its role in pre-T-cell acute lymphoblastic leukemia (T-ALL)
The Role of MSH2 in Hereditary Non-Polyposis Colon Cancer
BIOLOGY 12 Cancer.
PTEN Tumor Suppressor Extraordinaire
Genomic alterations in breast cancer cell line MDA-MB-231.
BMP Receptor 1a and Juvenile Polyposis Syndrome
M.B.Ch.B, MSC, PhD, DCH (UK), MRCPCH
Genetic Damage and Mutation
Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours By: Anh Pham.
Small RNAs and Immunity
Presentation transcript:

WT1: Wilms’ Tumor gene by Jennifer Mackey

Wilms’ Tumor o NEPHROBLASTOMA in children o Discovered by Max Wilms in 1899 o WT1 is a tumor suppressor o 10-15% due to WT1 inactivation Kidney MRI (Scott et al., 2001)

BUT, MUTATED WT1 IS ALSO FOUND IN OTHER CANCERS!!

AND AS WE WILL SEE - IT IS NOT ALWAYS A TUMOR SUPPRESSOR!!!

WT1 is alternatively spliced to make many protein isoforms (Wagner, K.D. et al., 2003)

WT1 is a transcription factor (Scholz, H. et al., 2005) (Exon 9)(Exon 5)

WT1 is a transcription factor

WT1’s normal biological functions o Development of genitourinary system o Development of kidney o Adult kidney o Heart development o Neuron development?

WT1 -/- dies E12-birth no kidneys no gonads severe abnormalities of retinal development wtKO (Kreidberg et al., 1993)

WT1 -/- dies E12-birth no kidneys no gonads severe abnormalities of retinal development WT1 +/- increased mortality due to adult onset nephrotic syndrome & renal failure

WT1 is required for kidney development (Scholz, H. et al., 2005)

ADULT KIDNEY

(Scharnhorst, V. et al., 2001) WT1 is part of a transcriptional regulatory network That is critical for kidney development

(Scharnhorst, V. et al., 2001) WT1 is part of a transcriptional regulatory network That is critical for kidney development WT1 TARGET GENES INVOLVED IN KIDNEY DEVELOPMENT: Amphiregulin: stimulates uretic bud BCL-2: encodes antiapoptotic protein E-cadherin: mesenchyme condensation

REMEMBER: WT1 = differentiation

WT1 = PROLIFERATION!!

Wilms tumor Most are sporadic and unilateral 10-15% of sporadic have WT1 inactivation Most others have high levels of WT1 expression ~10% are bilateral and/or multifocal

Wilms tumor Most are sporadic and unilateral 10-15% of sporadic have WT1 inactivation Most others have high levels of WT1 expression ~10% are bilateral and/or multifocal WAGR (Wilms’ tumor, Aniridia, Genitourinary abnormalities, Mental retardation) Germline deletion Predisposition to WT

Wilms tumor Most are sporadic and unilateral 10-15% of sporadic have WT1 inactivation Most others have high levels of WT1 expression ~10% are bilateral and/or multifocal WAGR (Wilms’ tumor, aniridia, genitourinary abnormalities, mental retardation) Germline deletion Predisposition to WT Denys-Drash Syndrome (DDS) Germline mutations (missense mutation in zinc finger domain) Dominant-negative activity Predisposition to WT

Wilms tumor Most are sporadic and unilateral 10-15% of sporadic have WT1 inactivation Most others have high levels of WT1 expression ~10% are bilateral and/or multifocal WAGR (Wilms’ tumor, aniridia, genitourinary abnormalities, mental retardation) Germline deletion Predisposition to WT Denys-Drash Syndrome (DDS) Germline mutations (missense mutation in zinc finger domain) Dominant-negative activity Predisposition to WT Frasier Syndrome Germline point mutation in the intron 9 donor splice site Loss of KTS (-) = ratio disturbed WT very rare!

Acute myeloid leukemia(AML): WT1 overexpressed in leukemic blasts

Acute myeloid leukemia(AML): WT1 overexpressed in leukemic blasts Breast cancer: expression of WT1 detected in majority of BC’s evaluated

Acute myeloid leukemia(AML): WT1 overexpressed in leukemic blasts Breast cancer: expression of WT1 detected in majority of BC’s evaluated Renal cell carcinoma: overexpression of WT1 in tubular epithelial cells in adulthood

80% of tumors can be treated successfully!!!

REFERENCES Kreidberg, Jordan A. et al WT-1 Is Required for Early Kidney Development. Cell 74: Loeb, David M. and Saraswati Sukumar The Role of WT1 in Oncogenesis: Tumor Suppressor or Oncogene? International Journal of Hematology 76: Scharnhorst, Volkher et al WT1 proteins: functions in growth and differentiation. Gene 273: Scholz, Holger and Karin M. Kirschner A Role for the Wilms’ Tumor Protein WT1 in Organ Development. Physiology 20: Scott, Carly M. et al Wilms' Tumor: A Primary Care Case Study And Differential Diagnosis. The Internet Journal of Advanced Nursing Practice 5: Number 1. Wagner, K-D et al The complex life of WT1. Journal of Cell Science 116: Wagner et al Intermediate filament protein nestin is expressed in developing kidney and heart and might be regulated by the Wilms’ tumor suppressor WT1. American Journal of Physical Regul Integr Comp Physiology 291: R779-R787.